Home
RAMM Pharma

RAMM Pharma Market Share Analysis for February 2026

Industry: N/A

Domainrammpharma.com

Year Founded--

Employees51 - 200

Annual Revenue--

RAMM Pharma

RAMM Pharma (including company regionals)

rammpharma.com

See more website traffic and engagement information

RAMM Pharma Revenue up to February 2026 is --

revenue generated by RAMM Pharma top domains

RAMM Pharma top domains revenue over 3 years

Revenue for RAMM Pharma top domains

rammpharma.com--

See more with Sales Intelligence

Total visits to RAMM Pharma's top domains

Understand RAMM Pharma market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in RAMM Pharma's top domains

Analyze RAMM Pharma engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on RAMM Pharma's top domains

See how RAMM Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

RAMM Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by RAMM Pharma

These are the website technologies, by industry, used by RAMM Pharma top domains

Advertising (4)

Google Adsense

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

Social (2)

Instagram

More Technologies

6

See all

News & Signals from RAMM Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRAMM Pharma Corp. launches line of botanical-derived food supplements.RAMM Pharma Corp., a company traditionally known for cannabis-based products, is diversifying its portfolio by launching a new line of botanical-derived food supplements under its Marishanti brand.

NewsRAMM Pharma Corp. hires José Roldan as interim-Chief Financial Officer.RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM), is pleased to announce the appointment of José Roldan as interim-Chief Financial Officer of the Company, effective immediately.

NewsRAMM Pharma Corp. acquired Hempoland for $914K on Sep 7th '22.The Green Organic Dutchman Holdings has sold its subsidiary, HemPoland, to the cannabis firm RAMM Pharma for C$1.2m. RAMM Pharma Corp, a Canadian firm specialising in the research and development of cannabinoid pharmaceutical formulations, has acquired all of the issued and outstanding shares of HemPoland from The Green Organic Dutchman Holdings (TGOD).